Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Prognostic Significance for Long-Term Outcomes Following Radical Prostatectomy in Men with Prostate Cancer: Evaluation with Prostate Imaging Reporting and Data System Version 2.

Kim R, Kim CK, Park JJ, Kim JH, Seo SI, Jeon SS, Lee HM.

Korean J Radiol. 2019 Feb;20(2):256-264. doi: 10.3348/kjr.2018.0613.

2.

Prediction of biochemical recurrence after radical prostatectomy with PI-RADS version 2 in prostate cancers: initial results.

Park SY, Oh YT, Jung DC, Cho NH, Choi YD, Rha KH, Hong SJ.

Eur Radiol. 2016 Aug;26(8):2502-9. doi: 10.1007/s00330-015-4077-5. Epub 2015 Nov 11.

PMID:
26560721
3.

Biparametric Prostate Imaging Reporting and Data System version2 and International Society of Urological Pathology Grade Predict Biochemical Recurrence after Radical Prostatectomy.

Takeuchi N, Sakamoto S, Nishiyama A, Horikoshi T, Yamada Y, Iizuka J, Maimaiti M, Imamura Y, Kawamura K, Imamoto T, Komiya A, Ikehara Y, Akakura K, Ichikawa T.

Clin Genitourin Cancer. 2018 Aug;16(4):e817-e829. doi: 10.1016/j.clgc.2018.02.011. Epub 2018 Feb 24.

PMID:
29576444
4.

Does the Prostate Imaging-Reporting and Data System (PI-RADS) version 2 improve accuracy in reporting anterior lesions on multiparametric magnetic resonance imaging (mpMRI)?

Hoffmann R, Logan C, O'Callaghan M, Gormly K, Chan K, Foreman D.

Int Urol Nephrol. 2018 Jan;50(1):13-19. doi: 10.1007/s11255-017-1753-1. Epub 2017 Nov 29.

PMID:
29188489
5.

A Prospective Accuracy Study of Prostate Imaging Reporting and Data System Version 2 on Multiparametric Magnetic Resonance Imaging in Detecting Clinically Significant Prostate Cancer With Whole-mount Pathology.

Giannarini G, Girometti R, Crestani A, Rossanese M, Calandriello M, Cereser L, Bednarova S, Battistella C, Sioletic S, Zuiani C, Valotto C, Ficarra V.

Urology. 2019 Jan;123:191-197. doi: 10.1016/j.urology.2018.07.067. Epub 2018 Sep 28.

PMID:
30273613
6.

Multiparametric Magnetic-Resonance to Confirm Eligibility to an Active Surveillance Program for Low-Risk Prostate Cancer: Intermediate Time Results of a Third Referral High Volume Centre Active Surveillance Protocol.

Luzzago S, Musi G, Catellani M, Russo A, Di Trapani E, Mistretta FA, Bianchi R, Cozzi G, Conti A, Pricolo P, Ferro M, Matei DV, Mirone V, Petralia G, de Cobelli O.

Urol Int. 2018;101(1):56-64. doi: 10.1159/000488772. Epub 2018 May 7.

PMID:
29734177
7.

PI-RADS v2 and periprostatic fat measured on multiparametric magnetic resonance imaging can predict upgrading in radical prostatectomy pathology amongst patients with biopsy Gleason score 3 + 3 prostate cancer.

Zhai L, Fan Y, Sun S, Wang H, Meng Y, Hu S, Wang X, Yu W, Jin J.

Scand J Urol. 2018 Oct - Dec;52(5-6):333-339. doi: 10.1080/21681805.2018.1545799.

PMID:
30895901
8.

[Preliminary applicability evaluation of Prostate Imaging Reporting and Data System version 2 diagnostic score in 3.0T multi-parameters magnetic resonance imaging combined with prostate specific antigen density for prostate cancer].

Zuo MZ, Zhao WL, Wei CG, Zhang CY, Wen R, Gu YF, Li MJ, Zhang YY, Wu JF, Li X, Shen JK.

Zhonghua Yi Xue Za Zhi. 2017 Dec 19;97(47):3693-3698. doi: 10.3760/cma.j.issn.0376-2491.2017.47.003. Chinese.

PMID:
29325321
9.

Evaluation of the accuracy of multiparametric MRI for predicting prostate cancer pathology and tumour staging in the real world: an multicentre study.

Kam J, Yuminaga Y, Krelle M, Gavin D, Koschel S, Aluwihare K, Sutherland T, Skinner S, Brennan J, Wong LM, Louie-Johnsun M.

BJU Int. 2019 Feb 3. doi: 10.1111/bju.14696. [Epub ahead of print]

PMID:
30714285
10.

Standardized Reporting of Prostate MRI: Comparison of the Prostate Imaging Reporting and Data System (PI-RADS) Version 1 and Version 2.

Tewes S, Mokov N, Hartung D, Schick V, Peters I, Schedl P, Pertschy S, Wacker F, Voshage G, Hueper K.

PLoS One. 2016 Sep 22;11(9):e0162879. doi: 10.1371/journal.pone.0162879. eCollection 2016.

11.

Baseline Multiparametric MRI for Selection of Prostate Cancer Patients Suitable for Active Surveillance: Which Features Matter?

Sanguedolce F, Petralia G, Sokhi H, Tagliabue E, Anyamene N, Hellawell G, Padhani AR.

Clin Genitourin Cancer. 2018 Apr;16(2):155-163.e6. doi: 10.1016/j.clgc.2017.10.020. Epub 2017 Nov 21.

PMID:
29198639
13.

[Implications of PI-RADS Version 1 and Updated Version 2 on the Scoring of Prostatic Lesions in Multiparametric MRI].

Haas M, Günzel K, Penzkofer T, Maxeiner A, Fischer T, Miller K, Hamm B, Asbach P, Cash H.

Aktuelle Urol. 2016 Sep;47(5):383-7. doi: 10.1055/s-0042-111128. Epub 2016 Sep 28. German.

PMID:
27680189
14.

Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients.

Washino S, Okochi T, Saito K, Konishi T, Hirai M, Kobayashi Y, Miyagawa T.

BJU Int. 2017 Feb;119(2):225-233. doi: 10.1111/bju.13465. Epub 2016 Apr 1.

15.

Can Prostate Imaging Reporting and Data System Version 2 reduce unnecessary prostate biopsies in men with PSA levels of 4-10 ng/ml?

Xu N, Wu YP, Chen DN, Ke ZB, Cai H, Wei Y, Zheng QS, Huang JB, Li XD, Xue XY.

J Cancer Res Clin Oncol. 2018 May;144(5):987-995. doi: 10.1007/s00432-018-2616-6. Epub 2018 Mar 5.

PMID:
29504080
16.

Integration and Diagnostic Accuracy of 3T Nonendorectal coil Prostate Magnetic Resonance Imaging in the Context of Active Surveillance.

Curci NE, Lane BR, Shankar PR, Noyes SL, Moriarty AK, Kubat A, Brede C, Montgomery JS, Auffenberg GB, Miller DC, Montie JE, George AK, Davenport MS.

Urology. 2018 Jun;116:137-143. doi: 10.1016/j.urology.2018.02.043. Epub 2018 Apr 10.

PMID:
29653121
17.

Using the prostate imaging reporting and data system version 2 (PI-RIDS v2) to detect prostate cancer can prevent unnecessary biopsies and invasive treatment.

Liu C, Liu SL, Wang ZX, Yu K, Feng CX, Ke Z, Wang L, Zeng XY.

Asian J Androl. 2018 Sep-Oct;20(5):459-464. doi: 10.4103/aja.aja_19_18.

18.

The diagnostic value of PI-RADS V1 and V2 using multiparametric MRI in transition zone prostate clinical cancer.

Wang X, Bao J, Ping X, Hu C, Hou J, Dong F, Guo L.

Oncol Lett. 2018 Sep;16(3):3201-3206. doi: 10.3892/ol.2018.9038. Epub 2018 Jun 28.

19.

Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: Prostate Imaging Reporting and Data System Version 1 versus Version 2.

Feng ZY, Wang L, Min XD, Wang SG, Wang GP, Cai J.

Chin Med J (Engl). 2016 Oct 20;129(20):2451-2459. doi: 10.4103/0366-6999.191771.

20.

Diagnostic Performance and Interobserver Consistency of the Prostate Imaging Reporting and Data System Version 2: A Study on Six Prostate Radiologists with Different Experiences from Half a Year to 17 Years.

Ke Z, Wang L, Min XD, Feng ZY, Kang Z, Zhang PP, Li BS, You HJ, Hou SC.

Chin Med J (Engl). 2018 Jul 20;131(14):1666-1673. doi: 10.4103/0366-6999.235872.

Supplemental Content

Support Center